Home News Lupin signs licence, supply pact with Spektus to commercialise DeslaFlex in Canada News Lupin signs licence, supply pact with Spektus to commercialise DeslaFlex in Canada February 16, 2026 FacebookTwitterPinterestWhatsAppLinkedin Shares of Lupin Ltd ended at ₹2,216.50, up by ₹17.30, or 0.79%, on the BSE.Read More RELATED ARTICLESMORE FROM AUTHOR News Goyal urges industry to raise quality standards to achieve $2 trillion export target News PM Narendra Modi to inaugurate Noida International Airport in March, says Yogi Adityanath AI AI startup Emergent scales at record speed by letting anyone build apps on their phone 13,000FansLike9,000FollowersFollowMost PopularAll AllFeaturedAll time popular Air India Face Rs 15,000 Crore Loss This Financial Year Uncategorized January 24, 2026 How a personal health crisis sparked a scalable protein venture from... Uncategorized February 11, 2026 Preventify Raises ₹2 Crore Pre-Seed Funding Led by PedalStart to Expand... Uncategorized February 9, 2026 Union Budget 2026 proposes setting up of rare earth corridors in... Uncategorized February 1, 2026 Sun TV Network Q3 Results: Net profit falls 10% on decline... News February 6, 2026
